4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
BioAge Labs, Inc. (BIOA) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in EmeryVille, United States with about 60 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, BIOA reported $9M in revenue and ($81M) in net income.
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging.
Interactive charts & full statements → Open the BIOA valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $9M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($93M) | ($78M) | ($48M) | ($40M) |
| Net Income | ($81M) | ($71M) | ($64M) | ($40M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $3M | $3M | $2M | $2M | $2M | — |
| Operating Income (EBIT) | ($25M) | ($28M) | ($23M) | ($25M) | ($16M) | — |
| Net Income | ($22M) | ($26M) | ($20M) | ($22M) | ($13M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $295M | $358M | $26M | $28M |
| Total Liabilities | $23M | $35M | $199M | $141M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BIOA viewer.
About TickerBase · Data methodology & sources